Ann: AEB enters R&D partnership with The University of Sydney, page-9

This is all great, and I would hope they would be working towards seizing said opportunities for all stakeholders (including themselves) however will they be able to materialize any of these potential products/revenue streams in time to avoid multiple CR, dilutions, exiting out the back door etc.

I'm certainly not arguing they won't rise "1000% in 2 years" but to bring a product from research/testing to commercialization and then to bring the company into foreseeable profit to cause them to be at 16c a share ~$150m MC would certainly take some alignment of the stars, and more importantly a steadfast management team. But this is specs, where everything, nothing and anything in-between is possible and whilst I find your optimism both here and on the QBL front refreshing, I am becoming increasing cynical of these fresh faces in buzzword industries.